tiprankstipranks
Senti Biosciences (SNTI)
NASDAQ:SNTI
US Market

Senti Biosciences (SNTI) Financial Statements

86 Followers

Senti Biosciences Financial Overview

Senti Biosciences's market cap is currently ―. The company's EPS TTM is $-1.441; its P/E ratio is -0.23; Senti Biosciences is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue--$ 338.00K$ 937.00K$ 1.29M
Gross Profit-$ 500.00K$ 338.00K$ 687.00K$ 1.04M
EBIT$ -14.51M$ -7.53M$ -42.41M$ -18.75M$ -18.68M
EBITDA$ -13.05M$ -6.06M$ -40.69M$ -17.97M$ -18.29M
Net Income Common Stockholders$ -12.11M$ 8.73M$ -42.41M$ -18.70M$ -18.68M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 23.72M$ 35.93M$ 39.43M$ 59.63M$ 76.11M
Total Assets$ 102.19M$ 119.48M$ 131.77M$ 143.63M$ 161.43M
Total Debt$ 36.72M$ 37.67M$ 37.31M$ 38.24M$ 37.92M
Net Debt$ 13.00M$ 1.74M$ -2.12M$ -21.39M$ -38.18M
Total Liabilities$ 46.09M$ 52.57M$ 48.83M$ 46.21M$ 49.09M
Stockholders Equity$ 56.09M$ 66.91M$ 82.94M$ 97.42M$ 112.34M
Cash Flow-
Free Cash Flow$ -11.70M$ -6.94M$ -17.42M$ -17.25M$ 3.37M
Operating Cash Flow$ -11.68M$ -7.04M$ -15.56M$ -13.58M$ 3.37M
Investing Cash Flow$ -15.00K$ 101.00K$ 21.34M$ 18.23M$ -9.60M
Financing Cash Flow-$ 556.00K$ -23.00K$ 281.00K$ -35.00K
Currency in USD

Senti Biosciences Earnings and Revenue History

Senti Biosciences Debt to Assets

Senti Biosciences Cash Flow

Senti Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis